Iradimed Corp
IRMD
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.16B
Close$
$55.32
40.6% downside
Current Fair Value
40.6% downsideOvervalued by 40.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.16 Billion |
|---|---|
| Enterprise Value | $1.11 Billion |
| Dividend Yield | $1.24 (1.36%) |
| Earnings per Share | $1.77 |
| Beta | 0.91 |
| Outstanding Shares | 12,783,000 |
Return
| Return on Equity | 22.66% |
|---|---|
| Return on Assets | 20.05% |
| Return on Invested Capital | 26.91% |
Valuation & Multiples
| P/E Ratio | 50.2 |
|---|---|
| PEG | -521.34 |
| Price to Sales | 15.52 |
| Price to Book Ratio | 13.3 |
| Enterprise Value to Revenue | 12.81 |
| Enterprise Value to EBIT | 38.84 |
| Enterprise Value to Net Income | 47 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 31, 2026
EPS Estimate
$0.44
Average shareholder expectationRevenue Estimate
$20.35 M
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$0.55
Average shareholder expectationRevenue Estimate
$23.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 76.38% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.92%▼ 57.05% |
|---|---|
| Total Invested | $35.59M▼ 95.15% |
| Investors Holding | 47▼ 185.00% |
ESG Score
No data
About Iradimed Corp
CEO: Roger Susi